United States and Europe EndoAVF Device Industry Valuation to Total USD 118.3 Million by 2034 Amid Growing Prevalence of End-stage Kidney Disease | FMI

United States and Europe EndoAVF Device Industry

As per Future Market Insights’ latest analysis, the United States & Europe EndoAVF device industry value is set to total USD 85.1 million in 2024. It will register steady growth, with EndoAVF device sales predicted to surge at 3.3% CAGR, totaling USD 118.3 million by 2034.

Demand remains high for single-catheter systems, rising at 3.4% CAGR. This can be attributed to their high adoption across healthcare facilities. Single-catheter systems are often simpler in design compared to dual-catheter systems. They are easier for healthcare professionals to handle and navigate during the endovascular procedure.

Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-19387

Multiple factors are set to propel demand for EndoAVF devices across the United States and Europe through 2034. These include a growing incidence of end-stage renal disease (ESRD) and an escalating preference for minimally invasive procedures like EndoAVF.

In 2018, the prevalence of ESKD was 242 per million in the United States. This figure is anticipated to increase further due to rise in diabetes, hypertension, glomerulonephritis, and cystic kidney disease, creating growth prospects for EndoAVF device industry.

Today, both patients and healthcare professionals are showing a preference for minimally invasive procedures like EndoAVF. This is due to side effects associated with conventional surgical procedures. Courtesy of this, demand for EndoAVF devices is set to grow steadily across the United States and Europe.

Key Takeaways from the Report:

• The United States & Europe EndoAVF device industry is set to total USD 118.3 million by 2034.
• Based on product, single-catheter system demand is forecast to rise at 4% CAGR through 2034.
• By technology, thermal resistance held an 1% value share in 2024.
• By end-user, the hospital segment will record a CAGR of 6% from 2024 to 2034.
• The United States industry value is predicted to total USD 52.54 million in 2024.
• Demand in Germany is set to grow at 2% CAGR through 2034.

“Spike in kidney diseases and growing preference for minimally invasive surgeries are anticipated to fuel growth of the EndoAVF device industry in the United States and Europe through 2034,” says a lead analyst of Future Market Insights (FMI).

Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-19387

Who is Winning?

Leading EndoAVF device manufacturers are focusing on new product launches and approvals to stay ahead of the competition. They are establishing new research and development facilities to develop innovative EndoAVF solutions. Various companies are employing strategies like mergers, partnerships, and distribution agreements.

Recent Developments:

• In June 2023, BD strengthened its manufacturing ability with the inauguration of a €4 million research and development facility in Blackrock, Dublin. It also invested €30 million to strengthen its manufacturing facility in Enniscorthy, Wexford.
• In February 2019, BD received 510(k) approval from the U.S. Food and Drug Administration for their BD WavelinQ 4 French (4F) EndoAVF system.

Key Companies Profiled:

• BD
• Medtronic Plc

Industry Segmentation:

By Product:

• Single-catheter system
• Dual-catheter system

By Technology:

• Thermal Resistance
• Radiofrequency Pulse

By End-user:

• Hospitals
• Ambulatory Surgical Centers
• Dialysis Centers

By Country:

• United States
• Germany
• United Kingdom
• France
• Italy
• Spain

A Full Report Overview: https://www.futuremarketinsights.com/checkout/19387

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube